These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28629361)

  • 41. Decoy receptor 3 promotes cell adhesion and enhances endometriosis development.
    Tsai HW; Huang MT; Wang PH; Huang BS; Chen YJ; Hsieh SL
    J Pathol; 2018 Feb; 244(2):189-202. PubMed ID: 29057478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
    Sung HY; Wu HG; Ahn JH; Park WY
    Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice.
    Tang CH; Hsu TL; Lin WW; Lai MZ; Yang RS; Hsieh SL; Fu WM
    J Biol Chem; 2007 Jan; 282(4):2346-54. PubMed ID: 17099218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNFSF/TNFRSF cytokine gene expression in sickle cell anemia: Up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma.
    Safaya S; Alfarhan M; Sulaiman A; Alsulaiman A; Al-Ali A
    Cytokine; 2019 Nov; 123():154744. PubMed ID: 31255916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
    Xiu Z; Shen H; Tian Y; Xia L; Lu J
    Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis.
    Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z
    J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
    Connor JP; Felder M
    Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
    Li W; Zhang C; Chen C; Zhuang G
    Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
    Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
    Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
    Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.
    Cheng CP; Sheu MJ; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2013 Apr; 52(4):609-22. PubMed ID: 23221330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effects of DcR3-SUMO on lipopolysaccharide-induced inflammatory cells and septic mice.
    Su J; Tong Z; Feng Z; Wu S; Zhou F; Li R; Chen W; Ye Z; Guo Y; Yao S; Yu X; Chen Q; Chen L
    Int J Biol Macromol; 2024 Aug; 275(Pt 2):133703. PubMed ID: 38986982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
    Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
    Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decoy receptor 3 is a prognostic factor in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
    Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decoy receptor 3 suppresses B cell functions and has a negative correlation with disease activity in rheumatoid arthritis.
    Chen MH; Liu PC; Chang CW; Chen YA; Chen MH; Liu CY; Leu CM; Lin HY
    Clin Exp Rheumatol; 2014; 32(5):715-23. PubMed ID: 25084482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis.
    Hayashi S; Miura Y; Tateishi K; Takahashi M; Kurosaka M
    Mod Rheumatol; 2010 Feb; 20(1):63-8. PubMed ID: 19821006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of macrophage differentiation and activation by decoy receptor 3.
    Chang YC; Hsu TL; Lin HH; Chio CC; Chiu AW; Chen NJ; Lin CH; Hsieh SL
    J Leukoc Biol; 2004 Mar; 75(3):486-94. PubMed ID: 14657214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.